(Q34987420)

5 August 2017

1 reference

title

Molecular alterations in sporadic breast cancer (English)

1 reference

5 August 2017

Lerebours F

1

1 reference

PubMed ID

12413631

5 August 2017

Lidereau R

series ordinal

2

1 reference

5 August 2017

1 November 2002

1 reference

Critical Reviews in Oncology Hematology

5 August 2017

1 reference

5 August 2017

44

1 reference

5 August 2017

121-141

1 reference

5 August 2017

2

1 reference

Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

S-phase fraction and breast cancer--a decade of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Molecular cytogenetics of primary breast cancer by CGH

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

11q13 amplification in local recurrence of human primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Instability of short tandem repeats (microsatellites) in human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Genetic instability in colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutations of mitotic checkpoint genes in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Abnormal centrosome amplification in the absence of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Deletion mapping of chromosomal region 1p32-pter in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Allelic imbalance on chromosome I in human breast cancer. II. Microsatellite repeat analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Allelic imbalance on chromosome 1 in human breast cancer. I. Minisatellite and RFLP analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Proximal 6q, a region showing allele loss in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Infrequent somatic mutations of the p73 gene in various human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutations in the RAD54 recombination gene in primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

A point mutation in the MET oncogene abrogates metastasis without affecting transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Roles for Nkx3.1 in prostate development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of the ATM gene is significantly reduced in sporadic breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

ATM protein synthesis patterns in sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Overexpression of BRCA2 gene in sporadic breast tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Growth retardation and tumour inhibition by BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Maspin is an angiogenesis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of epidermal growth factor receptor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of FGF and FGF receptor genes in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Insulin-like growth factors in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Cyclin D1 protein expression and function in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection ofcyclin D1 in breast andcyclin E in ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Abnormal expression of MDM-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

DNA methylation in the promoter region of the p16 (CDKN2/MTS-1/INK4A) gene in human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Prognostic role of p27Kip1 and apoptosis in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

G1-S transition defects occur in most breast cancers and predict outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

WAF1/CIP1 protein expression in human breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

1 reference

7 January 2021

Immunohistochemistry of cyclin D1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Defining a role for c-Myc in breast tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Bcl-2 gene family and related proteins in mammary gland involution and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Cyclin E, a redundant cyclin in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Can ends justify the means?: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Telomerase activity, cell proliferation, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Telomerase activity and survival of patients with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Telomerase catalytic subunit homologs from fission yeast and human

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Creation of human tumour cells with defined genetic elements

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

TP53 tumor suppressor gene: a model for investigating human mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The molecular epidemiology of p53 gene mutations in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

p53 mutation as a genetic trait of typical medullary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Structural rearrangement of the retinoblastoma gene in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

BRCA1 mutations in primary breast and ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Low incidence of BRCA2 mutations in breast carcinoma and other cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

BRCA2 mutations in primary breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutation analysis in the BRCA2 gene in primary breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Pleiotropic defects in ataxia-telangiectasia protein-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

E-cadherin germline mutations in familial gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Estrogen receptor variants and mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Oestrogen receptor mutants and variants in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Estrogen receptor variants in normal human mammary tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Transforming growth factor alpha and mouse models of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Transforming growth factor-beta in breast cancer: a working hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Association of BRCA1 with Rad51 in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Murine Brca2: sequence, map position, and expression pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Involvement of Brca2 in DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Molecular genetic studies of early breast cancer evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Multistep carcinogenesis of breast cancer and tumour heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Classical gene amplifications in human breast cancer are not associated with distant solid metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900191-3

7 January 2021

10.1016/S1040-8428(01)00191-3

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12413631